Scientists Create Cancer-Fighting Chewing Gum from Beans

A team of scientists at the University of Pennsylvania just created something that sounds like science fiction: chewing gum that fights cancer-causing microbes in your mouth.

The special gum reduced HPV levels by 93% in saliva samples from patients with head and neck squamous cell carcinoma, a cancer affecting the mouth and throat. When researchers added an antimicrobial peptide called protegrin, the gum dropped levels of two cancer-linked bacteria almost to zero.

Lead researcher Henry Daniell explains why gum works better than traditional pills. "Oral medicines get diluted in blood and are not suitable for concentrated local delivery at the site of infection," he says. The gum delivers treatment exactly where it's needed.

The secret ingredient comes from lablab beans, which naturally contain an antiviral protein called FRIL. This protein traps viruses by binding to their surface proteins and sticking them to the gum. Meanwhile, antibacterial proteins poke holes in harmful bacteria and eliminate them.

Here's the best part: the gum only targets the bad guys. It cleared out cancer-associated microbes without harming the beneficial bacteria that keep your mouth healthy.

The treatment focuses on three troublemakers linked to head and neck cancer: HPV, Porphyromonas gingivalis, and Fusobacterium nucleatum. While HPV infection has increased cancer rates, the two bacteria are associated with worse survival rates in patients with untreated or recurring oral cancer.

The Bright Side

The gum isn't meant to replace existing treatments but to work alongside them. Daniell emphasizes that patients should continue all other therapies while using the gum as a complement.

Some experts urge caution about the real-world impact. Paolo Serafini from the University of Miami points out that we don't know how long the gum keeps bacteria and viruses away, estimating maybe an hour. He also notes that the HPV vaccine already prevents most head and neck cancers without any chewing required.

Still, clinical trials are moving forward. The antiviral chewing gum is currently being evaluated in London, and similar trials for head and neck cancer patients will soon begin at the University of Pennsylvania.

The research represents a creative new approach to cancer prevention that's affordable, easy to use, and targets the problem right at its source.